Suchergebnisse - "IL-6 antagonist"

PubPharm (9)

1

Review of Satralizumab for Neuromyelitis Optica Spectrum Disorder : A New Biologic Agent Targeting the Interleukin-6 Receptor

enthalten in: Cureus | 2024

von Meher, B. | Mohanty, R. | Dash, A.

2

Tocilizumab vs. baricitinib in hospitalized severe COVID-19 patients : results from a real-world cohort

enthalten in: Infection | 2023

von Karolyi, M. | Gruebl, A. | Omid, S. | +14

3

A Prospective Cohort Study of COVID-19 : Evaluation of the Early Role of IL-1 and IL-6 Antagonists in Improving the Outcome of the Illness and Reduction in the Risk of Death

enthalten in: Healthcare (Basel, Switzerland) | 2023

von Al Kharusi, M. | Al Sheikh, N. | Alhajri, M. | +5

4

Rare presentation of multiple thromboses in Erdheim-Chester disease : a case-based review

enthalten in: International journal of hematology | 2022

von Liu, Y. | Huang, C. | Meng, X. | +4

5

Interleukin-6 Antagonists : Lessons From Cytokine Release Syndrome to the Therapeutic Application in Severe COVID-19 Infection

enthalten in: Journal of pharmacy practice | 2022

von Meanwatthana, J. | Majam, T.

6

IL-6 antagonists to replace systemic corticosteroids as the preferred anti-inflammatory therapy in patients with COVID-19?

enthalten in: Cytokine | 2022

von Kow, C. | Zaihan, A. | Ramachandram, D. | +1

7

Pharmacological considerations for the treatment of COVID-19 in people living with HIV (PLWH)

enthalten in: Expert opinion on pharmacotherapy | 2021

von Gutierrez, M. | Mur, I. | Mateo, M. | +2

8

Tocilizumab in patients with severe COVID-19 : A single-center observational analysis

enthalten in: Journal of medical virology | 2020

von Knorr, J. | Colomy, V. | Mauriello, C. | +1

9

Structure-activity relationship study of a series of novel oxazolidinone derivatives as IL-6 signaling blockers

enthalten in: Bioorganic & medicinal chemistry letters | 2016

von Singh, S. | Gajulapati, V. | Gajulapati, K. | +9

1
[1]